{
 "@context": "https://schema.org",
 "@type": "Claim",
 "@id": "https://wulfkaal.github.io/positions/2026-07-31-5633",
 "identifier": "kaal:position:2026-07-31-5633",
 "additionalType": "https://wulfkaal.github.io/positions/schema.json#AffirmedPositionClaim",
 "name": "Historical 1Aa8A9495C5B4566Eae8",
 "text": "Artificial intelligence for optimization of immunotherapy: current applications and transformative potential should be assessed against Kaal's source-bound claim that When disruptive firms do not comply with existing rules or write their own exemptions because no appropriate rules exist, consumer protection and public safety goals are undermined and incumbent firms still bound by the rules suffer severe competitive disadvantages. The current metadata indicates a plausible connection through model context protocol, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.",
 "author": {
  "@type": "Person",
  "name": "Wulf A. Kaal",
  "identifier": "https://orcid.org/0009-0008-7840-1847"
 },
 "datePublished": "2026-07-31",
 "dateModified": "2026-07-31",
 "creativeWorkStatus": "Affirmed",
 "responseType": "qualification",
 "keywords": [
  "regulatory-failure",
  "innovation"
 ],
 "scope_conditions": [
  "disruptive products or services that fall outside or evade the existing regulatory framework",
  "External evidence level: abstract indexed.",
  "Mapping review tier: ambiguity triage before claim review.",
  "The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence."
 ],
 "currentDebate": {
  "name": "Artificial intelligence for optimization of immunotherapy: current applications and transformative potential",
  "url": "https://www.semanticscholar.org/paper/4ca02714be062cc1500ae5975d7bd5fdb5930f1b"
 },
 "extends": {
  "identifier": "kaal:claim:2740477-009",
  "url": "https://wulfkaal.github.io/claims/2740477-009",
  "citation": "Wulf A. Kaal, Erik P.M. Vermeulen, Venture Capital as Dynamic Regulation of Disruptive Innovation (2016). SSRN: https://ssrn.com/abstract=2740477",
  "paper": "Erik P.M. Vermeulen, Venture Capital as Dynamic Regulation of Disruptive Innovation",
  "authors": [
   "Wulf A. Kaal"
  ],
  "year": "2016",
  "ssrn": "https://ssrn.com/abstract=2740477",
  "source_pdf_sha256": "c72871b76fa2ad5a8a69ee8d3defc8f64e624be9052ce763e79cf6c58883f726"
 },
 "isBasedOn": [
  {
   "@id": "https://wulfkaal.github.io/claims/2740477-009"
  },
  {
   "@type": "CreativeWork",
   "name": "Artificial intelligence for optimization of immunotherapy: current applications and transformative potential",
   "url": "https://www.semanticscholar.org/paper/4ca02714be062cc1500ae5975d7bd5fdb5930f1b"
  }
 ],
 "batch_id": "historical-backfill:2026-07-31:phase-0023",
 "review_provenance": "https://kaal-signal-desk.wulf577462.chatgpt.site/#review",
 "publicationStatus": "public",
 "recordTypeNote": "Dated commentary position extending a scholarly corpus claim. Not a verbatim claim extracted from the paper.",
 "isPartOf": {
  "@id": "https://wulfkaal.github.io/positions/index.json"
 },
 "version": "1.0",
 "canonical_url": "https://wulfkaal.github.io/positions/2026-07-31-5633",
 "canonicalForm": "https://wulfkaal.github.io/positions/2026-07-31-5633.md",
 "candidateId": "kaal:response-candidate:2026-07-31:39de5ebea966b3e2",
 "evidenceLevel": "abstract indexed",
 "reviewTier": "ambiguity triage before claim review",
 "mappingConfidence": 0.2012,
 "mappingAmbiguous": true,
 "mappingMethod": "idf-weighted multi-field mapping v1",
 "mappingWhyRelevant": "Shared high-information concepts: not, safety, including, existing. Scope: disruptive products or services that fall outside or evade the existing regulatory framework.",
 "sourceProvenance": {
  "source": "Semantic Scholar",
  "api": "https://api.semanticscholar.org/graph/v1/paper/search/bulk",
  "query": "model context protocol",
  "queryId": "concept:9c5da690faad",
  "page": 1,
  "sourceRank": 299,
  "retrievedAt": "2026-07-31T13:58:04.059Z",
  "citationCount": 0,
  "venue": "Frontiers in Immunology",
  "publicationTypes": [
   "Review",
   "JournalArticle"
  ]
 },
 "userAffirmation": "Approved as written by Wulf A. Kaal on 2026-07-31.",
 "sha256": "22df259635c7866428c4ae5a31cead5d07fb5c3a238a4a41660b4f230710c3aa"
}